Technology-focused SPAC Cambridge Acquisition files for a $200 million IPO
February 6, 2026 News
SPAC Cambridge Acquisition prices $200 million IPO, targeting the technology sector
Cambridge Acquisition, a blank check company targeting the technology sector, raised $200 million by offering 20 million units at $10. Each unit consists of one share of common stock and one-third of one warrant, exercisable at $11.50.
IPO Overview
Cambridge Acquisition, a blank check company targeting the technology sector, filed on Monday with the SEC to raise up to $200 million in an initial public offering.
The company plans to raise $200 million by offering 20 million units at $10.00. Each unit consists of one share of common stock and one-third of one warrant exercisable at $11.50.
Cambridge Acquisition is led by Chairman Michael Cam-Phung, the VP and Head of Medtech Solutions Strategy at Tekni-Plex. He is joined by CEO and Director Brent Cox, the founder and Managing Principal of private investment firm Subtext Holdings, and CFO Anthony Naimo, the Managing Director of management consulting firm Procorso and CFO of Sarah Flint.
The SPAC plans to target businesses in the technology industry, particularly companies operating in sectors such as harm-reduction, wellness-oriented products, hemp-derived or functional botanical consumables, psychedelics, health-oriented markets, or technology-enabled platforms.
The Boston, MA-based company was founded in 2025 and plans to list on the Nasdaq under the symbol CAQUU. BTIG is the sole bookrunner on the deal.
About the Company
We are a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. Although we currently intend to focus on target businesses in the technology industry, we may pursue an acquisition opportunity in any business, industry, sector or geographical location. We intend to focus on industries that complement our management team’s background — in particular, high-growth, recession-resilient subsectors that are transitioning from misunderstood or underserved to mainstream markets. This may include companies operating in sectors such as harm-reduction, wellness-oriented products, hemp-derived or functional botanical consumables, psychedelics, health-oriented markets, or technology-enabled platforms.